Navigation Links
Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)
Date:12/8/2008

13; E: hth@genmab.com

Cautionary statement regarding forward-looking statements for GSK

Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company's Annual Report on Form 20-F for 2007.

Registered in England & Wales:

No. 3888792

Registered Office:

980 Great West Road

Brentford, Middlesex

TW8 9GS

Forward looking statement for Genmab

This press release contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with product discovery and development, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products obsole
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
10. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
11. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013 Research explores ... outcomes research also   to   be presented ... SHPG ), the global specialty biopharmaceutical company, announces that ... at the American Psychiatric Association (APA) 166th Annual Meeting ... The data being presented represent Shire,s ongoing commitment to ...
(Date:5/17/2013)...  ConvaTec today announced that it will report its 2013 first quarter ... CEO, and Ed Borkowski , CFO, will host an ... To participate in the conference call within the U.S. and ... in the conference call outside the U.S. and Canada ... Participants should dial in 10 minutes prior to the start ...
(Date:5/17/2013)... Puerto Rico , May 17, 2013 /PRNewswire/ ... western Puerto Rico , Caribbean Imaging and ... has improved its radiation therapy capabilities with the acquisition of ... Puerto Rico . Versa HD offers clinicians the versatility ... tumors throughout the body, while also enabling treatment of highly ...
Breaking Medicine Technology:Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
... BPH, Clinical Benefit After Ozarelix Was Maintained For ... Up ... End Or Soon Thereafter, IRVINE, Calif., Sept. 5 Spectrum,Pharmaceuticals, Inc., ... for ozarelix, the Company,s drug candidate for the,treatment of benign prostatic hypertrophy ...
... analyses of three-year,follow-up data showed that the CYPHER(R) ... to bypass surgery in patients,with blockages in two ... presented this week at the European Society of ... these analyses sought to assess the long-term impact ...
Cached Medicine Technology:Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 2Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 3Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 4Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 5Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 2Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 3Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 4Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 5
(Date:5/18/2013)... 2013 Although obesity is associated with ... between obesity and esophageal adenocarcinoma, a type of esophageal ... As reported on Cancer.gov, last reviewed in ... as likely as those of normal and healthy weight ... obesity and esophageal cancer is not well understood, it ...
(Date:5/18/2013)... May 18, 2013 Show And Go Training, ... various different training systems that is all about is getting ... the attention of http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting ... is a unique “four phase system” designed to make you ... of time spent working out in the gym. The training ...
(Date:5/18/2013)... Losing weight remains to be the biggest ... of new weight loss products available in the market today, ... about this newest weight loss supplement prove that dieting and ... Garcinia Cambogia is a sub-tropical fruit that is shaped like ... can suppress a person’s appetite, while it effectively burns fat ...
(Date:5/18/2013)... John Ravera, D.D.S., a Newport Beach ... new member to his dental team, Courtney Marino. , Marino ... for over 10 years. She received her degree from West ... a member of Sigma Pi Alpha, a national honor society ... with patients of all ages, helping them understand the importance ...
(Date:5/18/2013)... UT (PRWEB) May 18, 2013 Medical device ... orders for its much anticipated mobility aid with its namesake, ... create a hands-free crutch alternative that injured individuals ... broken ankle, for example, can remain active and walk during ... is using its reservation system to ensure those who need ...
Breaking Medicine News(10 mins):Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:FlexLeg Begins Offering New Mobility Aid 2
... Mental health screening has been demonstrated to successfully connect ... with school-based mental health services, according to results of ... for Mental Health Checkups at Columbia University. The study ... the Community Mental Health Journal . ...
... C., -- June 14, 2011 Over the past ... and promise of personalized medicine. Scientists are just beginning ... populations in regards to disease prevention and treatment. ... and the laboratories of Floyd H. "Ski" Chilton, Ph.D., ...
... , TUESDAY, June 14 (HealthDay News) -- Some ... -- especially young white girls who are being pushed by ... a new study. "There is a significant amount ... to minimize body weight, but this pressure as it relates ...
... 2011 News media registration is now open for ... in Denver, Aug. 28-Sept. 1, 2011. The event will include ... health, food and nutrition, energy, the environment, and other fields ... of the largest scientific conferences of 2011, the meeting will ...
... The European Society of Cardiology (ESC) Working Group of Atherosclerosis ... the profile of vulnerable plaques and the need for greater ... paper, published online today in Thrombosis and Haemostasis , ... plaque rupture, and for the development of better diagnostics and ...
... By Amanda Gardner HealthDay Reporter , MONDAY, ... support for privatizing Medicare, even though most people agree the ... if it is to survive. Instead, respondents to ... June said the program should be shored up, in part, ...
Cached Medicine News:Health News:Screening helps African-American students connect with school-based mental health services 2Health News:Screening helps African-American students connect with school-based mental health services 3Health News:Ancestry plays vital role in nutrition and disease, study shows 2Health News:Ancestry plays vital role in nutrition and disease, study shows 3Health News:Young Girls May Lose Sleep Over Pressure to Be Thin 2Health News:ESC calls for research into vulnerable plaques 2Health News:Poll Finds Little Support for GOP Plan to Privatize Medicare 2Health News:Poll Finds Little Support for GOP Plan to Privatize Medicare 3
...
Tip is bent towards port for downward irrigation. 25G x 7/8in (.50 x 16mm)...
... LASIK surgery and other types of ... corneal interface and/or stromal bed. Flattened ... flap and helps elevate the flap ... x 7/8in (.40 x 22mm) Formed ...
... LASIK surgery and other types of refractive ... and/or stromal bed. Flattened tip provides easy ... the flap edge. Multiple ports provide multi-directional ... Formed 9mm from end tip flattened 1.5mm ...
Medicine Products: